11 – 20 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers
(
- Contribution to journal › Article
- 2006
-
Mark
Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down-regulating fibrinolysis
(
- Contribution to journal › Article
- 2005
-
Mark
Synthesis, Function, and Inactivation of Blood Coagulation Factor V.
(
- Thesis › Doctoral thesis (monograph)
- 2003
-
Mark
The regulation of factor Va activity by activated protein C -Importance of the individual activated protein C cleavage sites in factor Va
2003)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Superantigens from Staphylococcus aureus induce procoagulant activity and monocyte tissue factor expression in whole blood and mononuclear cells via IL-1 beta
(
- Contribution to journal › Article
- 2002
-
Mark
Structural pathology and functional analysis of vitamin K-dependent protein S
2002)(
- Thesis › Doctoral thesis (compilation)
- 2001
-
Mark
Three-dimensional model of the SHBG-like region of anticoagulant protein S: New structure-function insights
(
- Contribution to journal › Article
- 2000
-
Mark
EGF-like modules in blood coagulation proteins : Ca²+ binding, module interactions, structure and dynamics as studied by NMR spectroscopy
2000)(
- Thesis › Doctoral thesis (monograph)
- 1999
-
Mark
Pro- and anticoagulant mechanisms in coronary artery disease. Clinical studies on factor VII and resistance to activated protein C
1999)(
- Thesis › Doctoral thesis (compilation)
- 1997
-
Mark
Resistance to activated protein C a novel risk factor for venous thrombosis
1997)(
- Thesis › Doctoral thesis (compilation)